However, co-transplantation of autologous ASC-derived insulin-producing cells and hematopoietic stem cells showed a better response in individuals with type 1 diabetes (T1D) as compared with a similar allogeneic regimen [49]. The gene discussed is INS; the disease is type 1 diabetes mellitus.